SCHEMBL24292873

SCHEMBL24292873

C=C/C=C\C1=C(C)N=C(NCCOc2ccccc2Cl)C2(CCOCC2)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ RAB9A P51151 5/20 0.35
▸ NPC1 O15118 4/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HTR1A P08908 1/20 0.34
▸ ADRA1D P25100 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ ADRA1B P35368 1/20 0.34
▸ PKM P14618 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ AURKA O14965 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ HPGD P15428 3/20 0.31
▸ MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757029 0.78 MEN1 (0.41) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL17757905 0.68 MEN1 (0.42) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL17757743 0.68 MEN1 (0.41) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL17757549 0.67 MEN1 (0.41) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL17757053 0.63 DRD2 (0.41) MEN1KMT2ALMNAHTR1ADRD2
SCHEMBL17757034 0.62 GPR84 (0.36) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL1379940 0.60 RAB9A (0.44) MEN1KMT2ARAB9ANPC1PKM
SCHEMBL17757035 0.60 ACAT2 (0.34) MEN1KMT2ARAB9ANPC1HTR1A
SCHEMBL17757325 0.59 PIK3CA (0.39) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL1380879 0.58 MEN1 (0.43) MEN1KMT2ARAB9ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE48992-E1 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN-DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2022-03-29 — — US disclosed
Send feedback